Hakan Demirci
- Ophthalmology top 0.1%
- Epidemiology top 2%
- Oncology top 2%
- Molecular Biology top 10%
- Radiology, Nuclear Medicine and Imaging top 1%
- Co-authors
- Jerry A. ShieldsCarol L. ShieldsSantosh G HonavarRalph C. EagleBrian P. MarrVictor M. ElnerArman MashayekhiJacqueline Cater
- Topics
- Ocular Oncology and Treatments (108 papers)Retinal Diseases and Treatments (24 papers)Cutaneous Melanoma Detection and Management (23 papers)
- Cited by
- OphthalmologyDermatologyOncology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- United StatesTürkiyeCanada
In The Last Decade
Hakan Demirci
217 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 123
- Ophthalmology 3.3k
- Epidemiology 1.3k
- Oncology 1.3k
- Molecular Biology 936
- Radiology, Nuclear Medicine and Imaging 909
Countries citing papers authored by Hakan Demirci
This map shows the geographic impact of Hakan Demirci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakan Demirci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakan Demirci more than expected).
Fields of papers citing papers by Hakan Demirci
This network shows the impact of papers produced by Hakan Demirci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakan Demirci. The network helps show where Hakan Demirci may publish in the future.
Co-authorship network of co-authors of Hakan Demirci
This figure shows the co-authorship network connecting the top 25 collaborators of Hakan Demirci. A scholar is included among the top collaborators of Hakan Demirci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakan Demirci. Hakan Demirci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | Oral HIF-2α inhibitor belzutifan for ocular von Hippel-Lindau (VHL) disease | 4 |
| 10 | 21 | |
| 11 | 9 | |
| 12 | 10 | |
| 13 | 49 | |
| 14 | 10 | |
| 15 | 62 | |
| 16 | 35 | |
| 17 | Tissue-Based Microarray Expression of Genes Predictive of Metastasis in Uveal Melanoma and Differentially Expressed in Metastatic Uveal Melanoma | 5 |
| 18 | 8 | |
| 19 | Autofluorescence of Choroidal Nevus in 64 Cases | 1 |
| 20 | 8 |
About Hakan Demirci
Hakan Demirci is a scholar working on Ophthalmology, Dermatology and Oncology, having authored 232 papers that have together received 5.5k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (108 papers), Retinal Diseases and Treatments (24 papers) and Cutaneous Melanoma Detection and Management (23 papers). The work is most often cited by research in Ophthalmology (3.3k citations), Dermatology (652 citations) and Oncology (1.3k citations). Hakan Demirci has collaborated with scholars based in United States, Türkiye and Canada. Frequent co-authors include Jerry A. Shields, Carol L. Shields, Santosh G Honavar, Ralph C. Eagle, Brian P. Marr, Victor M. Elner, Arman Mashayekhi, Jacqueline Cater, Christine C. Nelson and Arun D. Singh. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.